- Home
- FULC vs FLC Comparison
FULC vs FLC Comparison
Compare FULC & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- FLC
- Stock Information
- Founded
- FULC 2015
- FLC 2003
- Country
- FULC United States
- FLC United States
- Employees
- FULC N/A
- FLC N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- FLC Trusts Except Educational Religious and Charitable
- Sector
- FULC Health Care
- FLC Finance
- Exchange
- FULC Nasdaq
- FLC Nasdaq
- Market Cap
- FULC 221.5M
- FLC 180.6M
- IPO Year
- FULC 2019
- FLC N/A
- Fundamental
- Price
- FULC $3.25
- FLC $16.50
- Analyst Decision
- FULC Hold
- FLC
- Analyst Count
- FULC 10
- FLC 0
- Target Price
- FULC $7.44
- FLC N/A
- AVG Volume (30 Days)
- FULC 843.4K
- FLC 37.8K
- Earning Date
- FULC 11-13-2024
- FLC 01-01-0001
- Dividend Yield
- FULC N/A
- FLC 6.64%
- EPS Growth
- FULC N/A
- FLC N/A
- EPS
- FULC N/A
- FLC N/A
- Revenue
- FULC $80,871,000.00
- FLC N/A
- Revenue This Year
- FULC $2,821.96
- FLC N/A
- Revenue Next Year
- FULC N/A
- FLC N/A
- P/E Ratio
- FULC N/A
- FLC N/A
- Revenue Growth
- FULC 2987.86
- FLC N/A
- 52 Week Low
- FULC $2.86
- FLC $12.62
- 52 Week High
- FULC $13.70
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- FULC 44.64
- FLC 33.24
- Support Level
- FULC $2.86
- FLC $16.45
- Resistance Level
- FULC $3.94
- FLC $16.70
- Average True Range (ATR)
- FULC 0.23
- FLC 0.15
- MACD
- FULC 0.02
- FLC -0.03
- Stochastic Oscillator
- FULC 36.11
- FLC 6.85
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.